文献速递头颈部肿瘤放疗姑息放疗与转移瘤

头颈部肉瘤患者接受根治性放疗与手术治疗的结局

Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery.
PubMed 文献 · Pract Radiat Oncol · 2024-06-06

单中心回顾性分析1968至2020年192例非转移性头颈部软组织肉瘤患者,中位随访82个月。术后放疗134例(70%),术后放疗剂量中位60 Gy高于术前50 Gy(P < .001)。放疗时序与局部控制无关,切缘阳性/不确定是局部控制的唯一相关变量(HR 2.54),局部控制与疾病特异性生存相关(HR 4.48)。术后放疗组主要伤口并发症发生率低于术前放疗组(7.5% vs 22.4%,HR 0.28)。

要点

  • 切缘阳性/不确定是局部控制的唯一独立相关因素(HR 2.54,95%CI 1.34-4.82,P = .004)。
  • 局部控制与疾病特异性生存显著相关(HR 4.48,95%CI 2.62-7.67,P < .001)。
  • 术后放疗组主要伤口并发症发生率低于术前放疗组(7.5% vs 22.4%,HR 0.28,95%CI 0.11-0.68,P = .005)。

核心结论

  • 头颈部软组织肉瘤的局部控制仍相对差于躯干或四肢软组织肉瘤。
  • 局部控制与疾病特异性生存相关。
  • 放疗时序不影响肿瘤学结局或长期毒性结局,但术前放疗增加发生主要伤口并发症的机会。

研究设计与样本

  • 单中心回顾性综述,纳入1968年至2020年接受根治性手术联合放疗的非转移性头颈部软组织肉瘤患者192例。
  • 采用Kaplan-Meier法估计疾病特异性生存和局部控制,采用Cox比例风险模型进行多变量分析。

主要发现

  • 192例患者中位随访82个月;肿瘤位于颈部50例(26%)、鼻旁窦36例(19%)、面部23例(12%)。
  • 134例(70%)接受术后放疗;术后放疗剂量中位60 Gy高于术前放疗剂量中位50 Gy(P < .001)。
  • 放疗时序与局部控制无关:术前放疗78%(95%CI 63%-88%)vs 术后放疗75%(95%CI 66%-82%),P = .48。
  • 多变量分析中切缘阳性/不确定是唯一与局部控制相关的变量(HR 2.54,95%CI 1.34-4.82,P = .004);局部控制对疾病特异性生存的多变量分析HR 4.48(95%CI 2.62-7.67,P < .001)。
  • 术后放疗组主要伤口并发症发生率7.5% vs 术前放疗组22.4%(HR 0.28,95%CI 0.11-0.68,P = .005);术前与术后放疗组晚期毒性发生率无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Soft tissue sarcomas (STSs) of the head and neck (H&N) are rare malignancies that are challenging to manage. We sought to describe the outcomes of patients treated with curative intent using combined surgery and radiation therapy (RT) for H&N STS. METHODS AND MATERIALS: We performed a single-institution retrospective review of patients with nonmetastatic STS of the H&N who were treated from 1968 to 2020. The Kaplan-Meier method was used to estimate disease-specific survival (DSS) and local control (LC). Multivariable analyses (MVAs) were conducted using Cox proportional hazards model. RESULTS: One hundred ninety-two patients had a median follow-up of 82 months. Tumors arose in the neck (n = 50, 26%), paranasal sinuses (n = 36, 19%), or face (n = 23, 12%). Most patients were treated with postoperative RT (n = 134, 70%). Postoperative RT doses were higher (median, 60 Gy; preoperative dose, 50 Gy; P < .001). Treatment sequence was not associated with LC (preoperative RT, 78% [63%-88%]; postoperative RT, 75% [66%-82%]; P = .48). On MVA, positive/uncertain margin was the only variable associated with LC (hazard ratio [HR], 2.54; 95% CI, 1.34-4.82; P = .004). LC was significant on MVA (HR, 4.48; 95% CI, 2.62-7.67; P < .001) for DSS. Patients who received postoperative RT were less likely to experience a major wound complication (7.5% vs 22.4%; HR, 0.28; 95% CI, 0.11-0.68; P = .005). There was no difference in the rate of late toxicities between patients who received preoperative or postoperative RT. CONCLUSIONS: H&N STS continues to have relatively poorer LC than STS of the trunk or extremities. We found LC to be associated with DSS. Timing of RT did not impact oncologic or long-term toxicity outcomes; however, preoperative RT did increase the chance of developing a major wound complication.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Yoder AK, Farooqi A, Mitra D, et al. Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery. Pract Radiat Oncol. 2024. PMID: 38851534. doi:10.1016/j.prro.2024.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。